Latest Alzheimer's news
FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
posted May 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Lecanemab for Alzheimer Disease Safe, Feasible in Real-World Practice
posted May 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
No Negative Psychological Impact Seen for Disclosing Aβ Status
posted May 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Exercise Link to Dementia Varies by Physical Activity Domain 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings Related Articles
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease 
Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers 
Sugar Restriction in First 1,000 Days From Conception Linked to Lower Risk for Dementia Monthly Specialist Briefings
Stay Connected
